|
Volume 272, Number 28,
Issue of July 11, 1997
pp. 17438-17443
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Cell-specific Expression of the Glucose-dependent
Insulinotropic Polypeptide Gene in a Mouse Neuroendocrine Tumor Cell
Line
(Received for publication, February 19, 1997)
Michael O.
Boylan
,
Lisa I.
Jepeal
,
Linda A.
Jarboe
and
M. Michael
Wolfe
From the Section of Gastroenterology, Boston University School of
Medicine and Boston Medical Center, Boston, Massachusetts 02118
Glucose-dependent insulinotropic
polypeptide (GIP) is a 42-amino acid gastrointestinal regulatory
peptide that, in the presence of glucose, stimulates insulin secretion.
GIP is expressed in K cells of the small intestine and in cells of the
submandibular salivary gland. Using a rat GIP cDNA as a specific
probe, we screened a number of established cell lines for the
expression of GIP mRNA. STC-1 cells, a cell line derived from a
mouse neuroendocrine tumor, were found to express high levels of GIP
mRNA. GIP-specific transcripts were not detected in other cell
lines tested, which included cells of intestinal, salivary, and
endocrine origin. Analysis of GIP-luciferase fusions identified two
promoters, a distal and a proximal promoter, upstream of the
translation initiation codon for GIP. The distal promoter, located
upstream of position +1, corresponds to the principal promoter of the
GIP gene and can promote cell-specific transcription. Sequential
deletion and site-directed mutational analysis of the distal promoter
demonstrated that the sequence between 193 and 182 determines
cell-specific expression of GIP. Contained in this region is a
consensus GATA motif, suggesting that a member of the GATA family of
DNA-binding proteins is involved in the cell-specific regulation of the
GIP gene.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Kim and J. M. Egan
The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
Pharmacol. Rev.,
December 1, 2008;
60(4):
470 - 512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Fujita, J. W. Y. Chui, D. S. King, T. Zhang, J. Seufert, S. Pownall, A. T. Cheung, and T. J. Kieffer
Pax6 and Pdx1 are required for production of glucose-dependent insulinotropic polypeptide in proglucagon-expressing L cells
Am J Physiol Endocrinol Metab,
September 1, 2008;
295(3):
E648 - E657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. I. Jepeal, Y. Fujitani, M. O. Boylan, C. N. Wilson, C. V. Wright, and M. M. Wolfe
Cell-Specific Expression of Glucose-Dependent-Insulinotropic Polypeptide Is Regulated by the Transcription Factor PDX-1
Endocrinology,
January 1, 2005;
146(1):
383 - 391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Chang, W. Y. Chey, B. Erway, D. H. Coy, and T.-M. Chang
Modulation of secretin release by neuropeptides in secretin-producing cells
Am J Physiol Gastrointest Liver Physiol,
August 1, 1998;
275(2):
G192 - G202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lovshin, J. Estall, B. Yusta, T. J. Brown, and D. J. Drucker
Glucagon-like Peptide (GLP)-2 Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor Signaling
J. Biol. Chem.,
June 8, 2001;
276(24):
21489 - 21499.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|